Wockhardt Shares Surge 10% as Zaynich Boosts Successful Liver Transplant Trial Outcome!
Wockhardt Ltd.’s stock reached a record high on Monday following the company’s announcement that a patient in the US was able to successfully undergo a liver transplant and resume chemotherapy because to its exclusive antibiotic, ZaynichTM. According to an exchange filing, the patient, who was receiving chemotherapy and stent implantation for bile duct cancer earlier … Read more
